Koers Repros Therapeutics Inc

Aandelen

26-01-18	Repros Announces Negative Opinion From the EMA for Enclomiphene
15-12-17	Repros Therapeutics Inc.® Receives Feedback Following an Oral Explanation with the European Medicines Agency
12-12-17	REPROS THERAPEUTICS INC. Rigrodsky & Long, P.A. Announces Investigation of Buyout
12-12-17	Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of Repros Therapeutics Inc. to Allergan plc is Fair to Shareholders
12-12-17	Repros Therapeutics Inc.® Announces Acquisition by Allergan plc

Toevoegen aan een lijst 0 geselecteerde Om deze functie te gebruiken moet u een klant of lid zijn. Inloggen Registreren	Verschil (%)	Varia. 5d.	Varia. 1j.	Varia. 3j.	Kap.($)
REPROS THERAPEUTICS INC	-.--%	+0,74%	-	-	0
LONZA GROUP AG	-1,41%	-1,51%	+0,70%	+6,02%	50,35 mld.
REVOLUTION MEDICINES, INC.	-0,29%	-2,81%	+387,81%	+591,82%	39,21 mld.
IQVIA HOLDINGS INC.	-0,49%	+1,48%	+31,16%	-6,46%	34,52 mld.
BEONE MEDICINES AG	+1,53%	+3,11%	+15,41%	+58,54%	34,6 mld.
CELLTRION, INC.	+1,68%	-0,62%	+3,30%	+27,34%	27,05 mld.
ASCENDIS PHARMA A/S	+1,13%	-3,11%	-	-	16,68 mld.
MEDPACE HOLDINGS, INC.	-1,29%	-0,52%	+69,24%	+117,60%	15,11 mld.
EUROFINS SCIENTIFIC SE	-0,69%	0,00%	+13,79%	+17,13%	13,85 mld.
ICON PUBLIC LIMITED COMPANY	+2,45%	+3,99%	+18,20%	-30,12%	13,18 mld.
Gemiddelde	+0,26%	+0,94%	+67,45%	+97,73%	27,17 mld.
Gewogen gemiddelde per kap.	+0,08%	+0,83%	+80,82%	+121,42%

Werknemers

Sector